Molecular genetics alterations and tumor behavior of sporadic vestibular schwannoma from the People's Republic of China

被引:24
作者
Bian, LG
Tirakotai, W
Sun, QF
Zhao, WG
Shen, JK
Luo, QZ
机构
[1] Univ Marburg, Neurochirurg Klin, Dept Neurosurg, D-35033 Marburg, Germany
[2] Shanghai Med Univ 2, Rui Jin Hosp, Dept Neurosurg, Shanghai, Peoples R China
[3] Shanghai Med Univ 2, Ren Ji Hosp, Dept Neurosurg, Shanghai, Peoples R China
关键词
loss of heterozygosity; NF2 gene mutation; Schwannomin/merlin expression; Vestibular Schwannoma;
D O I
10.1007/s11060-004-5176-3
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objectives: To analyze the molecular genetic alteration of sporadic vestibular schwannomas from the People's Republic of China and to correlate these alterations with the tumor behaviors. Methods: Four highly polymorphic microsatellite DNA markers were used to observe the frequency of loss of heterozygosity (LOH) in chromosome 22. The NF2 gene mutations were detected by Polymerase chain reaction-single-strand conformation polymorphism (PCR-SSCP) and DNA sequencing. The schwannomin/merlin (S/M) expression was examined using anti-NF2 (A-19) IgG under immunohistochemistry and western blot. The proliferative index (LI) of vestibular schwannoma was evaluated by proliferative cell nuclear antigen investigation. Results: Sixteen vestibular schwannomas (44.4%) showed allele loss. We found 22 mutations in 36 schwannomas. The LI and the growth rate of schwannomas with LOH or mutation were significantly higher than those without LOH or mutation. All of these vestibular schwannomas showed no immunoreaction to anti-NF2(A-19) IgG by immunohistochemistry. By immunoblotting technique, reduced expression of S/M was found in 31 cases (86%). The growth index of schwannomas with severely reduced expression of S/M was significantly higher than those with moderately reduced or normal expression. Conclusion: The molecular genetic changes in sporadic vestibular schwannomas from Chinese patients were similar to the previous reports. We demonstrate the relationship between tumor behaviors and genetic alteration (including LOH and mutation of NF2 gene). We propose that inactivation of S/M, may be an important step in tumorigenesis of sporadic vestibular schwannoma.
引用
收藏
页码:253 / 260
页数:8
相关论文
共 34 条
[21]  
Parry DM, 1996, AM J HUM GENET, V59, P529
[22]   ALTERATION IN A NEW GENE ENCODING A PUTATIVE MEMBRANE-ORGANIZING PROTEIN CAUSES NEUROFIBROMATOSIS TYPE-2 [J].
ROULEAU, GA ;
MEREL, P ;
LUTCHMAN, M ;
SANSON, M ;
ZUCMAN, J ;
MARINEAU, C ;
HOANGXUAN, K ;
DEMCZUK, S ;
DESMAZE, C ;
PLOUGASTEL, B ;
PULST, SM ;
LENOIR, G ;
BIJLSMA, E ;
FASHOLD, R ;
DUMANSKI, J ;
DEJONG, P ;
PARRY, D ;
ELDRIGE, R ;
AURIAS, A ;
DELATTRE, O ;
THOMAS, G .
NATURE, 1993, 363 (6429) :515-521
[23]  
Ruttledge MH, 1996, AM J HUM GENET, V59, P331
[24]   PRESYMPTOMATIC DNA AND MRI DIAGNOSIS OF NEUROFIBROMATOSIS-2 WITH MILD CLINICAL COURSE IN AN EXTENDED PEDIGREE [J].
SAINIO, M ;
STRACHAN, T ;
BLOMSTEDT, G ;
SALONEN, O ;
SETALA, K ;
PALOTIE, A ;
PALO, J ;
PYYKKO, I ;
PELTONEN, L ;
JAASKELAINEN, J .
NEUROLOGY, 1995, 45 (07) :1314-1322
[25]  
SAINZ J, 1993, ARCH OTOLARYNGOL, V119, P1285
[26]   The neurofibromatosis 2 tumor suppressor protein interacts with hepatocyte growth factor-regulated tyrosine kinase substrate [J].
Scoles, DR ;
Huynh, DP ;
Chen, MS ;
Burke, SP ;
Gutmann, DH ;
Pulst, SM .
HUMAN MOLECULAR GENETICS, 2000, 9 (11) :1567-1574
[27]   Neurofibromatosis 2 (NF2) tumor suppressor schwannomin and its interacting protein HRS regulate STAT signaling [J].
Scoles, DR ;
Nguyen, VD ;
Qin, Y ;
Sun, CX ;
Morrison, H ;
Gutmann, DH ;
Pulst, SM .
HUMAN MOLECULAR GENETICS, 2002, 11 (25) :3179-3189
[28]   Interdomain binding mediates tumor growth suppression by the NF2 gene product [J].
Sherman, L ;
Xu, HM ;
Geist, RT ;
SaporitoIrwin, S ;
Howells, N ;
Ponta, H ;
Herrlich, P ;
Gutmann, DH .
ONCOGENE, 1997, 15 (20) :2505-2509
[29]   Loss of the NF2 gene and merlin occur by the tumorlet stage of schwannoma development in neurofibromatosis 2 [J].
Stemmer-Rachamimov, AO ;
Ino, Y ;
Lim, ZY ;
Jacoby, LB ;
MacCollin, M ;
Gusella, JF ;
Ramesh, V ;
Louis, DN .
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 1998, 57 (12) :1164-1167
[30]   A NOVEL MOESIN-LIKE, EZRIN-LIKE, RADIXIN-LIKE GENE IS A CANDIDATE FOR THE NEUROFIBROMATOSIS-2 TUMOR SUPPRESSOR [J].
TROFATTER, JA ;
MACCOLLIN, MM ;
RUTTER, JL ;
MURRELL, JR ;
DUYAO, MP ;
PARRY, DM ;
ELDRIDGE, R ;
KLEY, N ;
MENON, AG ;
PULASKI, K ;
HAASE, VH ;
AMBROSE, CM ;
MUNROE, D ;
BOVE, C ;
HAINES, JL ;
MARTUZA, RL ;
MACDONALD, ME ;
SEIZINGER, BR ;
SHORT, MP ;
BUCKLER, AJ ;
GUSELLA, JF .
CELL, 1993, 72 (05) :791-800